Activist 13D/13G Filings - Gracell Biotechnologies Inc. (GRCL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
5:01 pm
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
RA CAPITAL MANAGEMENT L.P.48,600,221
9.99%
-79decrease
(-0.00%)
View
2024-02-14
08:20 am
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
William Cao Wei77,141,530
15.9%
-18,004,855decrease
(-18.92%)
View
2024-02-14
08:00 am
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Sio Capital Management LLC25,007,900
5.2%
25,007,900increase
(New Position)
View
2024-02-13
5:26 pm
Unchanged
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
LAV Biosciences Fund V L.P.25,406,680
5.3%
0
(Unchanged)
View
2024-02-13
5:00 pm
Unchanged
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Vivo Opportunity Fund Holdings L.P.38,152,030
7.7%
0
(Unchanged)
View
2023-10-19
08:10 am
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Temasek Holdings (Private) Ltd47,944,317
9.99%
-1,565,385decrease
(-3.16%)
View
2023-08-21
4:30 pm
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
RA CAPITAL MANAGEMENT L.P.48,600,300
9.99%
48,600,300increase
(New Position)
View
2023-08-18
4:56 pm
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Vivo Opportunity Fund Holdings L.P.38,152,030
7.8%
38,152,030increase
(New Position)
View
2023-08-11
4:23 pm
Purchase
13DGRACELL BIOTECHNOLOGIES INC SP
GRCL
ORBIMED ADVISORS LLC7,641,531
8%
57,955increase
(+0.76%)
View
2023-03-31
4:48 pm
Purchase
13DGRACELL BIOTECHNOLOGIES INC SP
GRCL
ORBIMED ADVISORS LLC7,583,576
11.2%
1,612,904increase
(+27.01%)
View
2023-03-08
2:01 pm
Sale
13GDOXIMITY INC
DOCS
BlackRock Inc.
BLK
5,381,384
4.5%
-3,767,923decrease
(-41.18%)
View
2023-02-14
4:20 pm
Unchanged
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
ORBIMED ADVISORS LLC5,970,672
8.8%
0
(Unchanged)
View
2023-02-14
12:03 pm
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Frazier Life Sciences Public Fund L.P.0
0%
-17,104,865decrease
(Position Closed)
View
2023-02-13
3:54 pm
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Capital International Investors16,200,000
4.8%
-4,118,820decrease
(-20.27%)
View
2023-02-07
4:00 pm
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
William Cao Wei95,146,385
26.9%
1,914,845increase
(+2.05%)
View
2023-02-06
2:36 pm
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
WELLINGTON MANAGEMENT GROUP LLP0
0%
-21,460,705decrease
(Position Closed)
View
2023-02-03
12:10 pm
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
BlackRock Inc.
BLK
4,887,820
7.2%
4,887,820increase
(New Position)
View
2022-03-17
12:42 pm
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
Frazier Life Sciences Public Fund L.P.17,104,865
5.1%
17,104,865increase
(New Position)
View
2022-02-14
2:53 pm
Purchase
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
William Cao Wei93,231,540
26.9%
93,231,540increase
(New Position)
View
2022-02-11
4:23 pm
Sale
13GGRACELL BIOTECHNOLOGIES INC SP
GRCL
ORBIMED ADVISORS LLC5,970,672
8.9%
-23,882,692decrease
(-80.00%)
View
Goto 0, 1, Next